Deciphera Pharmaceuticals Inc

General ticker "DCPH" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.2B

Deciphera Pharmaceuticals Inc follows the US Stock Market performance with the rate: 44.8%.

Estimated limits based on current volatility of 0.1%: low 25.57$, high 25.60$

Factors to consider:

  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 predicted range: [10.91$, 23.80$]
  • 2024-12-30 to 2025-12-30 predicted range: [10.58$, 23.28$]

Financial Metrics affecting the DCPH estimates:

  • Negative: Non-GAAP EPS of -2.29 <= 0.08
  • Negative: Operating Cash Flow per share of -1.72 <= 0.20
  • Negative: Operating Income to Revenue ratio of -0.56 <= 0.01
  • Negative: negative Net Income
  • Negative: Industry Operating Income to Revenue ratio (median) of -0.97 <= 0.02
  • Negative: Industry Operating Cash Flow per share (median) of -1.54 <= 0.29

Similar symbols

Short-term DCPH quotes

Long-term DCPH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $96.15MM $134.04MM $163.36MM
Operating Expenses $396.23MM $316.76MM $374.31MM
Operating Income $-300.08MM $-182.72MM $-210.96MM
Non-Operating Income $0.11MM $4.51MM $16.45MM
R&D Expense $257.04MM $187.82MM $234.12MM
Income(Loss) $-299.96MM $-178.21MM $-194.51MM
Taxes $0.00MM $0.72MM $0.43MM
Profit(Loss) $-299.96MM $-178.93MM $-194.94MM
Stockholders Equity $304.72MM $341.69MM $350.92MM
Assets $429.48MM $454.04MM $473.57MM
Operating Cash Flow $-240.82MM $-152.86MM $-146.70MM
Investing Cash Flow $176.85MM $-34.31MM $12.55MM
Financing Cash Flow $14.89MM $164.99MM $152.00MM
Earnings Per Share* $-5.11 $-2.37 $-2.29

* EPS are Split Adjusted, recent splits may be reflected with a delay.